HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.
Pediatric Vaccinology and Immunotherapy

As scientific progress accelerates, pediatric vaccinology and immunotherapy have become critical in both disease prevention and treatment. Beyond routine vaccines, this field explores therapeutic immunizations for conditions like asthma, food allergies, and autoimmune diseases. mRNA platforms and nanoparticle carriers now enable rapid vaccine development and improved immunogenicity. Immunotherapy in pediatrics, particularly for oncology, immunodeficiency, and allergic conditions, leverages monoclonal antibodies and cellular therapies to tailor responses. Ensuring age-appropriate immune activation without adverse outcomes is central to pediatric application. Global vaccination equity, cold-chain logistics, and public trust are recurring themes. Pediatric vaccinology and immunotherapy symbolize the fusion of innovation, policy, and ethical responsibility in shaping child health globally.

Committee Members
Speaker at Pediatrics and Neonatology 2027 - Peter Averkiou

Peter Averkiou

Florida Atlantic University, United States
Speaker at Pediatrics and Neonatology 2027 - Gabriella Di Rosa

Gabriella Di Rosa

University of Messina, Italy
Speaker at Pediatrics and Neonatology 2027 - Hanna A Alonim

Hanna A Alonim

Bar Ilan University, Israel
Speaker at Pediatrics and Neonatology 2027 - Marlene Fabiola Escobedo Monge

Marlene Fabiola Escobedo Monge

University of Valladolid, Spain
Tags

Submit your abstract Today

Twitter XTwitter
Watsapp